Ces Urol 2009, 13(3):207-210 | DOI: 10.48095/cccu2009014

Initial experience with intradetrusor application of botulinum A toxin in children with detrusor overactivity

Pavel Zerhau, Matej Husár
Urologické oddělení Kliniky dětské chirurgie, ortopedie a traumatologie FN Brno

Objective: Publication of initial experience gained from mini-invasive treatment of children?s bladder overactivity by an intradetrusor application of botulinum A toxin.
Material and method: During 2007/2008, 6 children at the age from 5 to 12 years were treated by endoscopic application of botulinum A toxin into detrusor; an application of this method has always followed, when the conservative treatment failed. In two cases, the urinary detrusor hyperactivity was neurogenic; the other four patients have non-neurogenic origin of overactivity. The botulinum A toxin in a dose of 10 IU/kg complying with the children body weight was applied into 25 or 30 detrusor points. Upon the subsequent evaluation, continence effect, urodynamic parameters and duration effect were considered.

Results: 5 patients have shown an improvement of urinary continence. An enlargement of bladder capacity by 84 % on the average was reached with all patients. In case of the 5 children, the intravesical pressure and non-inhibited contractions were reduced by 52% on the average. A maximum of improvement has appeared 3 months after the botulinumtoxin application, whereas lower values were recorded 6 or 9 months later.

Conclusion: An application of botulinum A toxin represents a safe alternative treatment for children suffering from detrusor hyperactivity, caused by neurogenic or non-neurogenic genesis. A direct intra-detrusor-application of botulinum A toxin means a distinct decrease of the non-inhibited contractions, reduction of the intravesical pressure, increase of the bladder capacity and improving of the urirary continence.

Keywords: neurogenic bladder, botulinum A toxin, detrusor overactivity, incontinence

Received: April 11, 2009; Accepted: May 11, 2009; Published: June 1, 2009 


References

  1. Dykstra DD, Sidi AA, Scott AB, et al. Effects of botulinum-A toxin on detrusor sphincter dyssynergia in spinal cord injury patients. J Urol 1988; 139: 919-922. Go to original source... Go to PubMed...
  2. Schurch R, Stöhrer M, Kamer G, Schmidt DM, et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients - a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000; 164: 692-694. Go to original source... Go to PubMed...
  3. Schulte-Baukloh H, Michael T, Schubert J, Stolze T, Knispel HH. Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 2002; 59: 325-327. Go to original source... Go to PubMed...
  4. Krhut J, Mainer K, Kopecký J. Botulotoxin A - alternativa v léčbě hyperaktivního měchýře. Čes Urol 2004; 2: 19.
  5. Krhut J, Kopecký J, Mainer K. Transuretrální injekce botulinumtoxinu v léčbě neurogenní hyperaktivity detruzoru. Čes Urol 2003; 1: 29.
  6. Krhut J. Hyperaktivní močový měchýř. Praha: Jessenius Maxdorf 2007; 148 s.
  7. Riccabona M, Koen M, Schindler M, Goedele B, et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 2004; 171: 845-848. Go to original source... Go to PubMed...
  8. Altaweel W, Jednack R, Bilodeau C, Corcos J. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol 2006; 175: 1102-1105. Go to original source... Go to PubMed...
  9. Chenet A, Perrouin-Verbe B, Le Normand L, Labat JJ, Brunel P, Lefort M, Mathé JF. Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity. Ann Readapt Med Phys 2007; 50(8): 651-660. Go to original source... Go to PubMed...
  10. Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, Van Laecke E. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 2006; 176(1): 328-330. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit